Indoco Remedies Limited (INDOCO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.162x

Based on the latest financial reports, Indoco Remedies Limited (INDOCO) has a cash flow conversion efficiency ratio of 0.162x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.58 Billion ≈ $17.06 Million USD) by net assets (Rs9.74 Billion ≈ $105.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check INDOCO capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Indoco Remedies Limited - Cash Flow Conversion Efficiency Trend (2004–2026)

This chart illustrates how Indoco Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. See INDOCO book value for net asset value and shareholders' equity analysis.

Indoco Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Indoco Remedies Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Eurocash S.A.
WAR:EUR
0.486x
Burcelik Vana Sanayi ve Ticaret AS
IS:BURVA
-2.892x
CCS Supply Chain Management Co Ltd
SHG:600180
0.028x
Trivium Real Estate Socimi SA
MC:YTRI
0.092x
Telecomunicações Brasileiras S.A. - TELEBRÁS
SA:TELB3
-0.032x
Sweeten Real Estate Development Co Ltd
TW:5525
-0.067x
Thanulux Public Company Limited
BK:TNL
-0.039x
Bank Woori Saudara Indonesia 1906
JK:SDRA
-0.049x

Annual Cash Flow Conversion Efficiency for Indoco Remedies Limited (2004–2026)

The table below shows the annual cash flow conversion efficiency of Indoco Remedies Limited from 2004 to 2026. For the full company profile with market capitalisation and key ratios, see market value of Indoco Remedies Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs9.32 Billion
≈ $100.81 Million
Rs324.30 Million
≈ $3.51 Million
0.035x +27.04%
2025-03-31 Rs10.18 Billion
≈ $110.13 Million
Rs278.90 Million
≈ $3.02 Million
0.027x -80.43%
2024-03-31 Rs11.10 Billion
≈ $120.10 Million
Rs1.55 Billion
≈ $16.80 Million
0.140x -19.54%
2023-03-31 Rs10.28 Billion
≈ $111.20 Million
Rs1.79 Billion
≈ $19.34 Million
0.174x -9.50%
2022-03-31 Rs9.05 Billion
≈ $97.83 Million
Rs1.74 Billion
≈ $18.80 Million
0.192x +79.71%
2021-03-31 Rs7.69 Billion
≈ $83.16 Million
Rs822.22 Million
≈ $8.89 Million
0.107x -40.85%
2020-03-31 Rs6.80 Billion
≈ $73.49 Million
Rs1.23 Billion
≈ $13.29 Million
0.181x -9.61%
2019-03-31 Rs6.61 Billion
≈ $71.44 Million
Rs1.32 Billion
≈ $14.29 Million
0.200x +10.00%
2018-03-31 Rs6.75 Billion
≈ $73.00 Million
Rs1.23 Billion
≈ $13.27 Million
0.182x +33.64%
2017-03-31 Rs6.52 Billion
≈ $70.46 Million
Rs886.40 Million
≈ $9.59 Million
0.136x -29.86%
2016-03-31 Rs5.84 Billion
≈ $63.19 Million
Rs1.13 Billion
≈ $12.26 Million
0.194x -8.10%
2015-03-31 Rs5.19 Billion
≈ $56.11 Million
Rs1.09 Billion
≈ $11.84 Million
0.211x -2.30%
2014-03-31 Rs4.57 Billion
≈ $49.47 Million
Rs988.09 Million
≈ $10.69 Million
0.216x +29.87%
2013-03-31 Rs4.14 Billion
≈ $44.78 Million
Rs688.69 Million
≈ $7.45 Million
0.166x +8.53%
2012-03-31 Rs3.85 Billion
≈ $41.61 Million
Rs589.71 Million
≈ $6.38 Million
0.153x +27.38%
2011-03-31 Rs3.50 Billion
≈ $37.87 Million
Rs421.36 Million
≈ $4.56 Million
0.120x -21.91%
2010-03-31 Rs3.11 Billion
≈ $33.58 Million
Rs478.40 Million
≈ $5.17 Million
0.154x +13.60%
2009-03-31 Rs2.78 Billion
≈ $30.11 Million
Rs377.64 Million
≈ $4.08 Million
0.136x +30.76%
2008-03-31 Rs2.54 Billion
≈ $27.50 Million
Rs263.71 Million
≈ $2.85 Million
0.104x +185.15%
2007-03-31 Rs2.33 Billion
≈ $25.20 Million
Rs84.76 Million
≈ $916.63K
0.036x -80.49%
2006-03-31 Rs1.98 Billion
≈ $21.45 Million
Rs369.86 Million
≈ $4.00 Million
0.186x +438.09%
2005-03-31 Rs1.75 Billion
≈ $18.96 Million
Rs60.74 Million
≈ $656.92K
0.035x -81.85%
2004-03-31 Rs880.11 Million
≈ $9.52 Million
Rs168.02 Million
≈ $1.82 Million
0.191x --

About Indoco Remedies Limited

NSE:INDOCO India Drug Manufacturers - Specialty & Generic
Market Cap
$203.35 Million
Rs18.80 Billion INR
Market Cap Rank
#16592 Global
#854 in India
Share Price
Rs204.00
Change (1 day)
+5.63%
52-Week Range
Rs164.00 - Rs339.10
All Time High
Rs511.66
About

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more